BUMPUS NAMANDJE received a stock award from RECURSION PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/23/2025ACC: 0001601830-25-000108
Director
Since Mar 2025
+33.02K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
33.02K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+11.01K
Price / share
—
Trade value
—
% of position
30.1%
6/18/2025
36.55K→47.56K
Total
Net shares
+11.01K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/18/2025 | A · Award | +11.01K | — | — | 30.1% | 36.55K | 47.56K |
| Total | +11.01K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Class A Common Stock
22.02K shares
Shares
+22.02K
Strike price
5.11
Held after
22.02K
Exercisable
—
6/18/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock22.02K shares | 6/18/2025 | A · Award | +22.02K | 5.11 | — | 22.02K |